¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"AIDS action."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® bacteriocidal action ÇÑ±Û »ì±ÕÀÛ¿ë
¼³¸í   
  È­Çпä¹ýÁ¦, ¼Òµ¶Á¦ Áß¿¡´Â ¹Ì»ý¹°À» »ç¸ê½Ã۴ ÀÛ¿ëÀÌ ÀÖ´Ù. À̰ÍÀ» »ì±ÕÀÛ¿ëÀ̶ó°í ÇÑ´Ù. ÀÌ¿¡ ´ëÇØ ¾î¶² ¾àÁ¦¿¡ ÀÇÇØ ±ÕÀÇ Áõ½ÄÀÌ ¾ïÁ¦°¡ µÇ´Âµ¥ ¾àÁ¦¸¦ Á¦°ÅÇϸ頴ٽàÁõ½ÄÇϴ °ÍÀ» Á¤±ÕÀÛ¿ëÀ̶ó ÇÑ´Ù.
¿µ¹® buffer action ÇÑ±Û ¿ÏÃæÀÛ¿ë
¼³¸í   
  Ç÷¾Ð, pH µî°ú °°ÀÌ »ýüÀÇ ±â´É ¹× »óŸ¦ ¾ÈÁ¤½Ã۰íÀÚ Çϴ ÀÛ¿ë : pH 7ÀΠ¼ø¼öÇÑ ¹°¿¡¼­ ¼Ò·®ÀÇ »ê ¶Ç´Â ¾ËÄ®¸®¸¦ °¡Çϸ頱נ¾ç¿¡ µû¶ó ¹°ÀÇ pH°¡ ¶Ñ·ÇÇϰԠº¯ÇÑ´Ù. ±×·¯³ª ¾àÇÑ »ê°ú ±× ¿°ÀǠȥÇÕ¿ë¾×, ¶Ç´Â ¾àÇÑ »ê±â¿Í ±× ¿°ÀǠȥÇÕ¿ë¾×À¸·Î ÀÌ·ç¾îÁö´Â °è¿¡¼­´Â ¾à°£ÀÇ »ê ¶Ç´Â ¾ËÄ®¸®¸¦ °¡Çصµ ¿ÏÃæÀÛ¿ë ¶§¹®¿¡ pH´Â °ÅÀÇ º¯ÇÏÁö ¾Ê´Â´Ù. ¿¹¸¦ µé¾î, ¾àÇÑ »ê°ú ±× ¿°ÀǠȥÇÕ¿ë¾×À¸·Î ÀÌ·ç¾îÁö´Â °èͧ¿¡ »êÀ» °¡ÇßÀ» ¶§¸¦ »ý°¢Çϸé, »ê¿¡ ÀÇÇØ¼­ °¡ÇØÁø ¼ö¼ÒÀ̿ H+Àº ¾àÇÑ »êÀ̿°ú °áÇÕÇÏ¿© ºñÇØ¸®ÀΠ»êÀÌ µÇ¾î pH°¡ º¯ÇÏÁö ¾Ê´Â´Ù. ¶Ç ¾ËÄ®¸®¸¦ °¡ÇßÀ» ¶§´Â °¡ÇØÁø ¼ö»êÀ̿ OH£­ÀÌ H+°ú °áÇÕÇÏ¿© ¹°À» ¸¸µé°í, ºÎÁ·ÇÑ H+Àº ºñÇØ¸® ¾àÇÑ »êÀÇ ÇØ¸®¿¡ ÀÇÇØ¼­ º¸ÃæµÇ¹Ç·Î½á ¿ª½Ã pH´Â º¯ÇÏÁö ¾Ê´Â´Ù. 
¿µ¹® bacteriostatic action ÇÑ±Û Á¤±ÕÀÛ¿ë
¼³¸í   
  È­Çпä¹ýÁ¦ÀÇ ¼¼±Õ¿¡ ´ëÇÑ ÀÛ¿ë Áß¿¡¼­ ¾î¶² ¾àÁ¦¸¦ ¼¼±Õ¿¡ ÀÛ¿ë½Ã۸é, ±ÕÀÇ Áõ½ÄÀº ¾ïÁ¦µÇ³ª ±× ¾àÁ¦°¡ Á¦°ÅµÇ¸é ÀçÂ÷ Áõ½ÄÇÑ´Ù. À̿͠°°Àº ÀÛ¿ëÀ» Á¤±ÕÀÛ¿ëÀ̶ó°í ÇÑ´Ù. ¿¹·Î¼­ Å¬·Î¶÷Æä´ÏÄÝ, ¼³ÆÄ¹Î µîÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AIDS
    ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • AIDS-dementia complex
    ¿¡ÀÌÁîÄ¡¸Åº¹ÇÕ
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • action
    1. ÀÛ¿ë 2. Ȱµ¿
  • action current
    Ȱµ¿Àü·ù
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • absorption action
    Èí¼öÀÛ¿ë
  • amphoteric action
    ¾çÂÊÀÛ¿ë
  • anabolic action
    ÇÕ¼º´ë»çÀÛ¿ë, µ¿È­ÀÛ¿ë
  • biphasic action potential
    ÀÌ»ó¼ºÈ°µ¿ÀüÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AIDS
    (¢¡ acquired immunodeficiency syndrome) ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
  • action
    ÀÛ¿ë, Ȱµ¿
  • absorption action
    Èí¼öÀÛ¿ë
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • bacteriocidal action
    »ì±ÕÀÛ¿ë
  • bacteriostatic action
    Á¤±ÕÀÛ¿ë
  • buffer action
    ¿ÏÃæÀÛ¿ë
  • diuretic action
    ÀÌ´¢ÀÛ¿ë
  • inhibitory action
    ¾ïÁ¦ÀÛ¿ë, ÀúÁöÀÛ¿ë
  • pharmacological action
    ¾à¸®ÀÛ¿ë
  • promotor action
    ÃËÁøÀÛ¿ë
  • action potential
    Ȱµ¿ÀüÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • action
    Ȱµ¿, ÀÛ¿ë
  • absorption action
    Èí¼öÀÛ¿ë
  • action current
    Ȱµ¿Àü·ù
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • amphoteric action
    ¾ç¼ºÀÛ¿ë
  • anabolic action
    µ¿È­ÀÛ¿ë
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • bacteriocidal action
    »ì±ÕÀÛ¿ë
  • bacteriostatic action
    Á¤±ÕÀÛ¿ë
  • buffer action
    ¿ÏÃæÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • AIDS
    ÈÄõ¼º¸é¿ª°áÇÌÁõ
  • ARC => AIDS-related complex
    ÈÄõ¼º¸é¿ª°áÇÌÁõ°ü·ÃÁõÈıº
  • acquired immunodeficiency syndrome (AIDS)
    ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
  • acquired immunodeficiency syndrome(AIDS)
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • aids=£¾acquired immune deficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõØóæ¹ÌÀù¹ñøý¦ÏØ)
  • HT2 receptors, action of hallucinogens
    5-ÇÏÀ̵å·Ï½ÃÆ®¸³Å¸¹Î2¼ö¿ëü
  • SDA= specific dynamic action
    ƯÀ̵¿Àû ÀÛ¿ë.
  • absorption action
    Èí¼öÀÛ¿ë.
  • action myoclonia
    Ȱµ¿°£´ë¼º ±Ù°æ·Ã(Áõ)(¡­ÊàÓÛàõÐÉÌâÕýñø)
  • action myoclonia
    Ȱµ¿°£´ë¼º ±Ù°æ·Ã(Áõ)(¡­ÊàÓÛàõÐÉÌâÕýñø).
  • action potential
    Ȱµ¿ÀüÀ§(¡­ï³êÈ), Ȱµ¿Àü¾Ð(¡­ï³äâ)
  • action tremor
    ÇàÀ§ÁøÀü(ú¼êÓòÉïµ).
  • action, bactericidal
    »ì±ÕÀÛ¿ë
  • action, bacteriostatic
    Á¤±ÕÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acquired immunodeficiency syndrome (AIDS)
    ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
  • acquired immunodeficiency syndrome(AIDS)
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • aids=£¾acquired immune deficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº(ý­ô¸àõØóæ¹ÌÀù¹ñøý¦ÏØ)
  • low vision aids
    Àú½Ã·Âº¸Á¶±â
  • visual aids
    ½Ã·Âº¸Á¶±â
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • absorption action
    Èí¼öÀÛ¿ë.
  • action myoclonia
    Ȱµ¿°£´ë¼º ±Ù°æ·Ã(Áõ)(¡­ÊàÓÛàõÐÉÌâÕýñø)
  • action myoclonia
    Ȱµ¿°£´ë¼º ±Ù°æ·Ã(Áõ)(¡­ÊàÓÛàõÐÉÌâÕýñø).
  • action potential
    Ȱµ¿ÀüÀ§(¡­ï³êÈ), Ȱµ¿Àü¾Ð(¡­ï³äâ)
  • action tremor
    ÇàÀ§ÁøÀü(ú¼êÓòÉïµ).
  • action, bactericidal
    »ì±ÕÀÛ¿ë
  • action, bacteriostatic
    Á¤±ÕÀÛ¿ë
  • additive action
    ºÎ°¡ÀÛ¿ë.
  • adverse action
    À¯ÇØ(êóúª)ÀÛ¿ë.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AIDS
    "(å²) acquired immuno-deficiency syndrome,¿¡ÀÌÁî"
  • AIDS virus
    AIDS ¹ÙÀÌ·¯½º
  • action current
    Ȱµ¿Àü·ù (üÀÔÑï³×µ)
  • action potential
    Ȱµ¿ÀüÀ§ (üÀÔÑï³êÈ)
  • action spectrum
    ÀÛ¿ë(íÂéÄ)½ºÆåÆ®·³
  • calorigenic action
    Ä®·Î¸®»ý¼ºÀÛ¿ë(ßæà÷íÂéÄ)
  • capillary action
    ¸ð¼¼°ü ÀÛ¿ë(Ù¾á¬Î·íÂéÄ)
  • law of mass action
    Áú·®ÀÛ¿ë¹ýÄ¢(òõÕáíÂéÄÛööÎ)
  • mass action
    Áú·®ÀÛ¿ë(òõÕáíÂéÄ)
  • mass-action ratio
    Áú·®ÀÛ¿ëÀ²(òõÕáíÂéÄëÒ)
  • photochemical action spectrum
    ±¤È­ÇÐÀÛ¿ë(ÎÃûùùÊíÂéÄ) ½ºÆåÆ®·³
  • photodynamic action
    ±¤¿ªÇÐ ÀÛ¿ë(ÎÃÕôùÊíÂéÄ)
  • protein-sparing action
    ´Ü¹éÁú Àý¾à ÀÛ¿ë(Ó±ÛÜòõï½å³íÂéÄ)
  • specific dynamic action
    ƯÀÌ µ¿Àû ÀÛ¿ë(÷åì¶ÔÑîÜíÂéÄ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • AIDS
    [=acquired immune defficiency syndrome] ÈÄõ¼º¸é¿ª°áÇÌÁõÈıº
  • action
    ÀÛ¿ë, Ȱµ¿, ±â´É
  • adverse action
    À¯ÇØÀÛ¿ë
  • duration (of action)
    Áö¼Ó½Ã°£
  • stop action imaging
    (Ȱµ¿)Á¤Áö»óÅ¿µ»ó
  • synergistic action
    »ó½ÂÀÛ¿ë, Çùµ¿ÀÛ¿ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
ADC AIDS Dementia Complex; AIDS Ä¡¸Å º¹ÇÕ
ARC AIDS Related Complex; AIDS °ü·Ã º¹ÇÕ
DAT delayed-action tablet; dementia Alzheimer's type; dental aptitude test; diacetylthiamine; diet as to...
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIDS-KS AIDS- related Kaposi's sarcoma
AIDS-KS AIDS-associated Kaposi sarcoma
AIDS-NHL AIDS-related non-Hodgkin lymphomas
ACTG AIDS Clinical Trials Group
ADC AIDS dementia complex
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 27430
    JournalTitle: AIDS action.
    MedAbbr: AIDS Action
    ISSN: 0953-0096
    ESSN:
    IsoAbbr:
    NlmId: 8900887
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • AIDS
    ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº, ÈÄõ¼º ¸é¿ª °áÇÌÁõ
    aquired immune deficiency syndromeÀÇ ¾àÀÚ. 1. ÈÄõÀûÀ¸·Î ¹ß»ýÇÑ ¸é¿ª °áÇÌ¿¡ ÀÇÇÏ¿© ÀϾ´Â ÁõÈıºÀ¸·Î ¼±ÅÃÀûÀ¸·Î ¼¼Æ÷ ¸Å°³¼º ¸é¿ªÀÌ °áÇ̵Ǹç ü¾× ¸Å°³¼º ¸é¿ªÀº °ÇÀüÇÏ´Ù. 1981³â°æºÎÅÍ ¹ß°ßµÇ¾î À¯Ç༺À¸·Î ÆÄ±ÞµÇ°í ÀÖ´Ù. °¨¿° °æ·Î´Â ¹ÐÁ¢ ÁÖ·Î µ¿¼º ¼º±³³ª Á¢ÃË ¶Ç´Â ¿À¿°µÈ »ç±â³ª Ç÷¾×ÀÇ ¼öÇ÷ µîÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ÀâÁ¾ ±Õ, ƯÈ÷
  • AIDS related complex
    AIDS °ü·Ã º¹ÇÕÁõ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ°ú ¿¬°üµÈ Áúȯ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ-°ü·Ã º¹ÇÕü, ÈÄõ¼º ¸é¿ª °áÇÌÁõ °ü·Ã º¹ÇÕ ¹ÝÀÀ
  • action mechanism
    ÀÛ¿ë ±âÀü
    ¾î¶² ±â´ÉÀÌ ÀϾ°Ô µÇ´Â °úÁ¤°ú °æ°ú.
  • action onset
    ÀÛ¿ë °³½Ã
  • action potential
    Ȱµ¿ ÀüÀ§, Ȱµ¿ Àü¾Ð
    ±ÙÀ°¼¼Æ÷ ¶Ç´Â ½Å°æ¼¼Æ÷°¡ ÈïºÐÇÒ ¶§ »ý±â´Â Àü±âÀû Ȱ¼ºÀ¸·Î¼­, Àü±âÀû, È­ÇÐÀû, ±â°èÀû ÀÚ±Ø ¹× ¿Âµµº¯È­ µî¿¡ ÀÇÇÏ¿© »ý±ä´Ù°í »ý°¢Çϰí ÀÖ´Ù.
  • action variable
    ÀÛ¿ë º¯¼ö
  • adverse action
    À¯ÇØÀÛ¿ë
  • analgetic action
    ÁøÅë ÀÛ¿ë
  • antagonistic action
    ±æÇ× ÀÛ¿ë
  • antidiuretic action
    Ç×ÀÌ´¢ÀÛ¿ë
  • antimicrobial action
    Ç×±Õ ÀÛ¿ë
  • antinociception action
    Ç×Ä§ÇØ¼ö¿ë¼º ÀÛ¿ë, Ç×À¯ÇØ ¼ö¿ë¼º ÀÛ¿ë
  • antipyretic action
    ÇØ¿­ ÀÛ¿ë
  • antispasmodic action
    Áø°æÀÛ¿ë
  • bactericidal action
    »ì±Õ ÀÛ¿ë, »ì±Õ¼º
    1. ¹ÚÅ׸®¾Æ¸¦ Á×ÀÌ´Â Çö»ó. ÀÌ ¿ë¾î´Â Á¾Á¾ Ç×»ýÁ¦ÀÇ ¼º°ÝÀ» ¼³¸íÇϴµ¥ »ç¿ëµÈ´Ù. 2. È­Çпä¹ýÁ¦, ¼Òµ¶Á¦ Áß¿¡´Â ¹Ì»ý¹°À» ¼Ò¸ê½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ´Ù. ÀÌ¿¡ ´ëÇØ ¾î¶² ¾àÁ¦¿¡ ´ëÇØ ±ÕÀÇ Áõ½ÄÀÌ ¾ïÁ¦µÇ´Âµ¥ ¾àÁ¦¸¦ Á¦°ÅÇÏ¸é ´Ù½Ã Áõ½ÄÇÏ´Â °ÍÀ» Áõ±Õ ÀÛ¿ëÀ̶ó ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
AIDS <immunology, syndrome> An epidemic disease caused by an infection by human immunodeficiency virus (HIV-1, HIV-2), a retrovirus that causes immune system failure and debilitation and is often accompanied by infections such as tuberculosis. AIDS is spread through direct contact with bodily fluids.
Acronym: AIDS
(10 May 1997)
aids-associated nephropathy Renal syndrome in human immunodeficiency virus-infected patients characterised by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients.
(12 Dec 1998)
AIDS-defining illness <immunology> One of a list of serious illnesses that occurs in HIV-positive individuals and is reason for an AIDS diagnosis according to the CDC's definition of AIDS.
Among these conditions are PCP, MAC, AIDS dementia complex, AIDS wasting syndrome, invasive cervical cancer, Kaposi's sarcoma and CMV retinitis.
(09 Oct 1997)
AIDS dementia <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
AIDS dementia complex <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
aids-related complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of kaposi's sarcoma, signaling the transition to the full-blown aids.
(12 Dec 1998)
aids-related opportunistic infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis carinii pneumonia, kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with mycobacterium avium complex, microsporidium, and cytomegalovirus.
(12 Dec 1998)
AIDS-related virus An obsolete term for human immunodeficiency virus.
(05 Mar 2000)
aids serodiagnosis Immunologic tests for identification of HIV (HTLV-III/lav) antibodies. They include assays for HIV seropositivity and HIV seronegativity (elisa, immunofluorescence, immunoblot, etc.) that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of aids or aids-related complex.
(12 Dec 1998)
AIDS test <investigation> A test which is performed on a standard venipuncture blood specimen which detects the presence of antibodies to HIV (virus). This test may not be positive for 3 to 6 months after infection with HIV.
(27 Sep 1997)
aids vaccines Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced.
(12 Dec 1998)
audiovisual aids Auditory and visual instructional materials.
(12 Dec 1998)
communication aids for disabled Equipment that provides mentally or physically disabled persons, who cannot speak effectively, with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesisers. The output of such aids includes written words, artificial speech, language signs, morse code, and pictures.
(12 Dec 1998)
hearing aids Devices which amplify sound to help persons with hearing loss.
(12 Dec 1998)
lymphoma, aids-related B-cell lymphoid tumours that occur in association with aids. Patients often present with an advanced stage of disease and highly malignant subtypes including burkitt lymphoma, immunoblastic large-cell lymphoma, small non-cleaved-cell lymphoma and diffuse large-cell lymphoma. The tumours are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in aids is a complex result of ebv infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • visual aids
    ½Ã°¢ ±³À°(¿ë ±â±¸)
  • action
    ¿òÁ÷ÀÓ,Çൿ,µ¿ÀÛ
  • action
    Ȱµ¿;ÀÛ¿ë;Çൿ;ÇàÀ§;µ¿ÀÛ;ÀÛ¿ë;¼Ò¼Û;ÀüÅõ;¼Ò¼³ÀÇ ÁٰŸ® Àü°³
  • civil action
    ¹Î»ç¼Ò¼Û
  • class action
    (°øµ¿ ÇÇÇØÀÚµéÀÇ)Áý´Ü ¼Ò¼Û
  • contact action
    Á¢ÃËÀÛ¿ë
  • covert action(operation)
    (°æÂû.Á¤º¸ºÎÀÇ)ºñ¹Ð°øÀÛ;ºñ¹Ðøº¸È°µ¿
  • cross action
    ¹Ý´ë ¼Ò¼Û;¹Ý¼Ò
  • delaying action
    Áö¿¬ Àü¼ú ÀÇ
  • direct action
    Á÷Á¢ Çൿ ±Ç¸®¸¦ À§ÇÑ ÆÄ¾÷(µ¥¸ð,½Ã¹ÎÀû ÀúÇ× µî)
  • disengaging action
    (±º)±³Àü ȸÇÇ;ÀÚ¹ßÀû ö¼ö
  • evasive action
    (Àü½Ã¿¡ ¼±¹Ú,Ç×°ø±â°¡ ÃëÇÏ´Â)ȸÇÇ Çൿ
  • friendly action
    ¿ìÈ£Àû ¼Ò¼Û
  • industrial action
    ³ëµ¿ÀÚÃøÀÇ ÀïÀÇ ÇàÀ§
  • mass action
    Áú·® ÀÛ¿ë
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á